| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | CA2305746A1 An efficient method for the conversion of nitriles to amidines |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305190A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/14/1999 | EP0907724A2 Von willebrand factor multimerase |
| 04/14/1999 | EP0907637A1 Phenylalamine derivatives as integrin inhibitors |
| 04/14/1999 | EP0907372A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
| 04/14/1999 | EP0907368A1 Novel heparin binding peptides |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0621789B1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/13/1999 | CA1340491C Interleukin-7 |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016863A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/08/1999 | WO1999016751A1 Benzamidine derivatives as factor xa inhibitors |
| 04/08/1999 | WO1999016750A1 Thrombin inhibitors |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1998055105A9 Fibrinogen-coated microspheres |
| 04/08/1999 | DE19743435A1 Benzamidinderivate Benzamidine derivatives |
| 04/08/1999 | CA2305568A1 Benzamidinderivates |
| 04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | CA2304007A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/08/1999 | CA2303832A1 Thrombin inhibitors |
| 04/07/1999 | EP0906340A1 Purification of factor viii complex by immunoaffinity chromatography |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
| 04/07/1999 | EP0906094A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 04/07/1999 | EP0906091A1 Amidinohydrazones as protease inhibitors |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0625164B1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/07/1999 | EP0607374B1 Novel cyclic lipid derivatives as potent paf antagonists |
| 04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/06/1999 | US5892014 DNA encoding a protease-activated receptor 3 |
| 04/06/1999 | US5892005 High molecular and low molecular fractions of von willebrand factor |
| 04/06/1999 | US5891909 Amidinohydrazones as protease inhibitors |
| 04/06/1999 | US5891900 Oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 04/06/1999 | US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives |
| 04/06/1999 | US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891843 Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
| 04/06/1999 | CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them |
| 04/01/1999 | WO1999015505A1 1,5-diphenylpyrazole derivatives |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015197A1 Preparation for the therapy of disorders related to blood clotting |
| 04/01/1999 | WO1999015196A1 Pharmaceutical substance containing various vitamin k-dependent factors |
| 04/01/1999 | WO1999015169A1 Thrombin inhibitors |
| 04/01/1999 | WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 04/01/1999 | WO1998057678A3 Compositions containing thrombin and microfibrillar collagen |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | CA2304396A1 A pharmaceutical preparation comprising vitamin k-dependent single factors |
| 04/01/1999 | CA2303359A1 1,5-diphenylpyrazole derivatives |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2301614A1 Thrombin inhibitors |
| 04/01/1999 | CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905233A2 Staphylococcus aureus trigger factor |
| 03/31/1999 | EP0904785A1 Protein C inhibitor against hypercoagulation |
| 03/31/1999 | EP0904783A1 Benzo(b)thiophene derivatives for lowering platelet counts |
| 03/31/1999 | EP0904367A1 Scf analog compositions and methods |
| 03/31/1999 | EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 03/31/1999 | EP0904285A1 Cyclic adhesion inhibitors |
| 03/31/1999 | EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 03/31/1999 | EP0904078A1 COMPOSITION COMPRISING A Katp CHANNEL INHIBITOR FOR USE IN THE TREATMENT OF HEMORRHAGIC SHOCK |
| 03/31/1999 | CN1212706A Serine protease inhibitors |
| 03/31/1999 | CN1212705A Serine protease inhibitors |
| 03/31/1999 | CN1212704A Serine protease inhibitors |
| 03/31/1999 | CN1212159A Asteriscus Pseudosciaenae pill and instant powder |
| 03/31/1999 | CN1042730C Method for preparing pyrazolopyridine compound |
| 03/30/1999 | US5889005 Benzamidine derivatives and their use for treating thrombotic diseases |
| 03/30/1999 | US5888965 Method of stimulating bone marrow regeneration |
| 03/30/1999 | US5888772 Amino acid sequences of mutants with higher biological activity; for treatment of anemia and induction of erythropoiesis |
| 03/30/1999 | CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts |
| 03/30/1999 | CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use |
| 03/25/1999 | WO1999014346A2 SENSE mRNA THERAPY |
| 03/25/1999 | WO1999014340A1 Human prl-1 phosphatase |
| 03/25/1999 | WO1999014229A1 Truncated aspartase enzyme derivatives and uses thereof |
| 03/25/1999 | WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/25/1999 | CA2304982A1 Sense mrna therapy |
| 03/25/1999 | CA2303227A1 Human prl-1 phosphatase |
| 03/24/1999 | EP0664786B1 Arginine keto-amide enzyme inhibitors |
| 03/24/1999 | EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 03/24/1999 | CN1211922A Associations of active principles containing clopidogrel and antithrombotic agent |
| 03/24/1999 | CN1211920A Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis |
| 03/24/1999 | CN1211423A Fe-Ca nutrient combination and its preparation method |
| 03/23/1999 | US5886146 Inhibitors of thrombosis |
| 03/23/1999 | US5885967 Anticoagulants |
| 03/23/1999 | US5885962 Stem cell factor analog compositions and method |